Skip to content

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Feasibility of a Community-Based Cancer Survivor Exercise and Nutrition Education Program: Effects on Self-Efficacy, Quality of Life and Functional Performance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06565260
Enrollment
150
Registered
2024-08-21
Start date
2026-09-01
Completion date
2029-08-30
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Brief summary

This clinical trial evaluates whether a supervised community-based exercise and nutrition program is usable and effective for improving cancer survivors' confidence for maintaining their physical activity and nutrition. Cancer survivors often experience problems with the musculoskeletal system (bones, joints, muscles, connective tissue), the cardiopulmonary system (heart, blood vessels and lungs) and the metabolic system (how the body's cells change food into energy) following treatment. There is substantial evidence that physical activity, diet, and weight management can improve quality of life (emotional and physical well-being) and physical fitness. Information gathered from this study may help researchers determine whether participating in a community-based exercise/nutrition training and education program may improve levels of fitness, cardiovascular health, and quality of life for cancer survivors.

Detailed description

PRIMARY OBJECTIVE: I. To assess the feasibility and acceptability of a 12-week supervised community-based exercise/nutrition training and education program for cancer survivors. SECONDARY OBJECTIVE: I. To assess the effectiveness of a supervised exercise and nutrition training and education program by evaluating pre-post changes in exercise self-efficacy. TERTIARY OBJECTIVE: I. To assess changes in functional performance and quality of life (QoL). OUTLINE: Patients participate in a supervised, community-based exercise program consisting of aerobic and resistance exercise over 45-60 minutes twice a week (BIW) for 12 weeks. Beginning at week 2, patients also receive nutrition education and training once a week (QW) for 10 weeks. Patients also wear an activity tracker throughout the study. After completion of study intervention, patients are followed up at 3 months.

Interventions

OTHERExercise Intervention

Participate in exercise program

OTHERMedical Device Usage and Evaluation

Wear an activity tracker

OTHERNutritional Intervention

Participate in nutrition program

OTHERPhysical Performance Testing

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Have had a previous cancer diagnosis and completed all therapy OR are a caregiver for a patient who has had a previous cancer diagnosis. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related interventions.

Exclusion criteria

* Have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia including atrial fibrillation (AFIB), multiple myeloma, or psychiatric illness/social situations that would limit compliance with study requirements. * Have orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise. * Are pregnant or nursing. * History of a stem cell transplant. * Currently on steroids. * Unwilling or unable to follow protocol requirements. * Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients still on study (Feasibility)At the end of the 12 week interventionFeasibility will be defined as the proportion of patients still on study at the end of the 12 weeks intervention. The feasibility rate will be estimated using a 90% credible region obtained by Jeffrey's prior method. The lower bound will define a plausible lower limit for true (unobserved) feasibility rate. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.
Percentage of patients on study after 12 weeks who complete at least 70% of intervention activities (Acceptability)At 12 weeksAcceptability will be determined by measuring adherence to the intervention. The adherence rate will be considered acceptable if patients complete at least 70% of the intervention activities. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.
Patient satisfaction (Acceptability)Baseline to 3 months post-interventionPatient satisfaction will be determined through surveys. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.

Secondary

MeasureTime frameDescription
Changes in exercise and nutrition self-efficacyBaseline to 3 months post-interventionThe self-reported outcomes will be summarized using the appropriate descriptive statistics. Self-reported outcomes will be compared using paired t-tests. Test assumptions will be verified graphically, and transformation or non-parametric methods (e.g., sign test) will be considered, as appropriate.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAndrew D Ray

Roswell Park Cancer Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026